PNC FINANCIAL SERVICES GROUP, INC. - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 187 filers reported holding MYRIAD GENETICS INC in Q1 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$102,110
-33.7%
6,366
-4.1%
0.00%
Q2 2023$153,914
-4.1%
6,640
-3.9%
0.00%
Q1 2023$160,450
+90.9%
6,907
+19.2%
0.00%
Q4 2022$84,056
-19.9%
5,793
+4.6%
0.00%
Q3 2022$105,000
+2.9%
5,537
-1.3%
0.00%
Q2 2022$102,000
-26.1%
5,610
+2.7%
0.00%
Q1 2022$138,000
-18.3%
5,463
-10.4%
0.00%
Q4 2021$169,000
+6.3%
6,100
+23.3%
0.00%
Q3 2021$159,000
-3.0%
4,947
-8.0%
0.00%
Q2 2021$164,000
+1.2%
5,378
+1.3%
0.00%
Q1 2021$162,000
+78.0%
5,311
+13.7%
0.00%
Q4 2020$91,000
+49.2%
4,672
+3.5%
0.00%
Q3 2020$61,000
+117.9%
4,516
+77.1%
0.00%
Q2 2020$28,000
-62.7%
2,550
-51.0%
0.00%
Q1 2020$75,000
-40.5%
5,207
+13.2%
0.00%
Q4 2019$126,000
+1.6%
4,600
+6.2%
0.00%
Q3 2019$124,000
+39.3%
4,332
+37.2%
0.00%
Q2 2019$89,000
-32.1%
3,158
-20.1%
0.00%
Q1 2019$131,000
+17.0%
3,950
+2.0%
0.00%
Q4 2018$112,000
-44.3%
3,871
-11.7%
0.00%
Q3 2018$201,000
+47.8%
4,386
+21.2%
0.00%
Q2 2018$136,000
+36.0%
3,618
+6.4%
0.00%
Q1 2018$100,000
-18.7%
3,401
-5.0%
0.00%
Q4 2017$123,000
+5.1%
3,579
+11.3%
0.00%
Q3 2017$117,000
+108.9%
3,217
+46.7%
0.00%
Q2 2017$56,000
-84.2%
2,193
-88.1%
0.00%
Q1 2017$354,000
+1375.0%
18,417
+1209.9%
0.00%
Q4 2016$24,000
-25.0%
1,406
-12.8%
0.00%
Q3 2016$32,000
-91.2%
1,612
-86.4%
0.00%
Q2 2016$362,000
-64.2%
11,868
-56.0%
0.00%
-100.0%
Q1 2016$1,010,000
+60.3%
26,958
+85.1%
0.00%0.0%
Q4 2015$630,000
+22.8%
14,561
+6.5%
0.00%0.0%
Q3 2015$513,000
-35.6%
13,666
-41.7%
0.00%0.0%
Q2 2015$797,000
-2.6%
23,429
+1.5%
0.00%0.0%
Q1 2015$818,000
+15.9%
23,081
+11.2%
0.00%0.0%
Q4 2014$706,000
+2.6%
20,749
+16.2%
0.00%0.0%
Q3 2014$688,000
+81.1%
17,853
+82.8%
0.00%
Q2 2014$380,000
+61.7%
9,764
+41.5%
0.00%
Q1 2014$235,000
+535.1%
6,902
+298.5%
0.00%
Q4 2013$37,000
-64.8%
1,732
-61.0%
0.00%
Q3 2013$105,000
-74.8%
4,436
-71.5%
0.00%
-100.0%
Q2 2013$417,00015,5620.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 5,809,799$205,667,0004.45%
Tieton Capital Management, LLC 146,650$5,191,0003.90%
KESTREL INVESTMENT MANAGEMENT CORP 614,275$21,745,0002.97%
Provident Investment Management, Inc. 375,032$13,276,0002.70%
Summit Street Capital Management, LLC 77,810$2,754,0002.46%
RATIONAL ADVISORS LLC 253,200$8,963,0002.17%
S&T BANK/PA 393,446$13,928,0002.08%
Euclidean Technologies Management, LLC 63,684$2,254,0002.05%
Grace Capital 220,769$7,815,0001.76%
AIMZ Investment Advisors, LLC 57,850$2,048,0001.75%
View complete list of MYRIAD GENETICS INC shareholders